Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Celon Pharma SA
SpeciCare
Shenzhen Second People's Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)